These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31613797)
1. Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma. Wei R; Ren X; Kong H; Lv Z; Chen Y; Tang Y; Wang Y; Xiao L; Yu T; Hacibekiroglu S; Liang C; Nagy A; Bremner R; Chen D JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31613797 [TBL] [Abstract][Full Text] [Related]
2. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina. Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148 [TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619 [TBL] [Abstract][Full Text] [Related]
6. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas. Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958 [TBL] [Abstract][Full Text] [Related]
7. Compensation by tumor suppressor genes during retinal development in mice and humans. Donovan SL; Schweers B; Martins R; Johnson D; Dyer MA BMC Biol; 2006 May; 4():14. PubMed ID: 16672052 [TBL] [Abstract][Full Text] [Related]
8. Von hippel-lindau disease: a genetic and clinical review. Haddad NM; Cavallerano JD; Silva PS Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046 [TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma. Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice. Wang Y; Yang J; Du G; Ma D; Zhou L Mol Carcinog; 2017 Oct; 56(10):2342-2351. PubMed ID: 28574654 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease. Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589 [TBL] [Abstract][Full Text] [Related]
12. CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181c. Deng Y; Li S; Li S; Yu C; Huang D; Chen H; Yin X IUBMB Life; 2020 Sep; 72(9):1920-1929. PubMed ID: 32584521 [TBL] [Abstract][Full Text] [Related]
13. Clinical Pathological Features and Current Animal Models of Type 3 Macular Neovascularization. Qiang W; Wei R; Chen Y; Chen D Front Neurosci; 2021; 15():734860. PubMed ID: 34512255 [TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related]
15. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. Stratmann R; Krieg M; Haas R; Plate KH J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235 [TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review. Chan CC; Collins AB; Chew EY Retina; 2007 Jan; 27(1):1-7. PubMed ID: 17218907 [TBL] [Abstract][Full Text] [Related]
17. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model. Bader HL; Hsu T BMC Cancer; 2016 Oct; 16(1):797. PubMed ID: 27733136 [TBL] [Abstract][Full Text] [Related]
19. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch. Arreola A; Payne LB; Julian MH; de Cubas AA; Daniels AB; Taylor S; Zhao H; Darden J; Bautch VL; Rathmell WK; Chappell JC JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467323 [TBL] [Abstract][Full Text] [Related]
20. VHL and PTEN loss coordinate to promote mouse liver vascular lesions. Chen S; Sanford CA; Sun J; Choi V; Van Dyke T; Samulski RJ; Rathmell WK Angiogenesis; 2010 Mar; 13(1):59-69. PubMed ID: 20221685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]